Immunomedics
Morris Plains
About Immunomedics
Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer and other serious diseases. Its corporate objective is to become a fully-integrated biopharmaceutical company. The company was founded in 1982 and headquartered in Morris Plains, New Jersey.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 101 – 250
- Total funding: $802.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (Dec 2019)
- Ticker: nasdaq:IMMU
- Website: immunomedics.com
- Phone: 973-605-8200
Industries & Categories
Biopharma, Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/immunomedics-26548 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.